We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Anticancer Therapies – Products

A lab worker pipetting a solution onto a plate.
Product News

FDA Grants Fast Track Designation to SonALAsense’s SONALA-001

Encouraging preliminary data from the ongoing DIPG clinical study to be presented at the 2023 Society for Neuro-Oncology Annual Meeting in Vancouver.
Cancer cells.
Product News

Xsphera Biosciences and NEX-I Collaborate To Advance Oncology Drug Research

Xsphera Biosciences, is pleased to announce the formalization of a Memorandum of Understanding (MOU) with NEX-I, a Seoul-based pioneer in immune-oncology therapeutics.
Unlocking the Potential of Cancer Immunotherapy with 3D Immune Cell Killing Assays
Whitepaper

Unlocking the Potential of Cancer Immunotherapy with 3D Immune Cell Killing Assays

This literature review explores the latest in 3D immune cell killing assays for cancer immunotherapy research.
Antibodies.
Product News

Lonza Further Extends Collaboration With Major Biopharmaceutical Partner for Manufacturing Antibody-Drug Conjugates

Extended long-term collaboration to provide significant additional bioconjugation capacity for commercialization of antibody-drug conjugates (ADCs) for use against hard-to-treat cancers.
Cancer cells.
Product News

CELLINK & Carcinotech Partner to Personalize Cancer Drug Development

Carcinotech and CELLINK plan to revolutionize the drug discovery market by leveraging CELLINK’s bioprinting solutions and Carcinotech’s expertise in producing 3D bioprinted living tumors to provide protocols for users to develop cutting-edge cancer models.
Representation of human cells.
Product News

Curiox Biosystems To Advance Next-Generation Cancer Cell Therapies Through Collaboration With Leading Cancer Researcher

Curiox Biosystems announces its collaboration with Dr. Marco Ruella, an assistant professor of medicine at the Perelman School of Medicine, to support efforts in the development of next-generation cancer cell therapies.
Drug Conjugates
Whitepaper

Antibody–Drug Conjugates: A Novel Paradigm for Cancer Therapy

This whitepaper highlights the key molecular components of ADCs and the challenges and opportunities for their future development.
The Gibco CTS Detachable Dynabeads.
Product News

Accelerating Cell Therapies with Manufacturing Breakthrough

Thermo Fisher announced a first of its kind technology to help accelerate the molecule-to-market process by driving efficiency and reducing manufacturing costs.
Comprehensive CAR-T Therapy Solutions
Product
Advertisement

Comprehensive CAR-T Therapy Solutions

With six CAR-T drugs currently approved by the FDA and more to follow, Sino Biological has committed to developing reagents and services to support our clients in CAR development, CAR-T preparation and lentivirus packaging, CAR-T cell expansion, and CAR-T quality control.
Cytokines for Cell Therapy Research
Product
Advertisement

GMP-Grade Cytokines for Cell Therapy Research

Sino Biological performs extensive quality control tests to ensure that GMP-grade cytokines meet rigorous quality standards, offering a range of GMP-grade cytokines
Advertisement